International Journal of Biochemistry and Biophysics,
Год журнала:
2023,
Номер
11(3), С. 27 - 34
Опубликована: Дек. 1, 2023
Parkinson's
disease
(PD)
is
the
second
most
prevalent
neurodegenerative
disorder,
following
Alzheimer's
disease,
impacting
approximately
1%
of
individuals
aged
60
and
older.It
characterized
by
degeneration
dopaminergic
neurons
in
SNpc,
resulting
both
motor
non-motor
symptoms.Current
treatments
are
limited,
PD's
molecular
basis
involves
alpha-synuclein
aggregation,
ubiquitination
dysregulation,
oxidative
stress.Nicotine,
found
tobacco,
has
been
associated
with
reduced
PD
risk
epidemiological
studies
shown
neuroprotective
effects
animal
models.However,
its
impact
on
stress
remains
unclear.A
study
involving
160
albino
laboratory
mice
investigated
nicotine's
an
MPTP-induced
model.The
were
divided
into
four
groups:
control,
nicotine,
MPTP,
MPTP
+
nicotine.The
assessed
behavioral
tests,
dopamine
levels
antioxidant
system
activity.Nicotine
improved
function,
increased
levels,
markers
model.Importantly,
it
selectively
enhanced
activity
enzymes,
superoxide
dismutase,
catalase,
PD-affected
without
affecting
healthy
animals.Nicotine
demonstrates
model,
ameliorating
deficits,
increasing
reducing
stress.It
enhances
key
enzymes
substantia
nigra,
suggesting
potential
therapeutic
avenues
for
treatment.However,
further
research
needed,
including
human
a
deeper
understanding
stress.These
results
contribute
to
our
pathogenesis
offer
insights
novel
approaches
this
debilitating
disorder.They
also
raise
questions
about
differential
nicotine
those
PD,
highlighting
need
targeted
interventions
diseases.
Biomolecules,
Год журнала:
2024,
Номер
14(6), С. 697 - 697
Опубликована: Июнь 14, 2024
The
antioxidant
defense
mechanisms
play
a
critical
role
in
mitigating
the
deleterious
effects
of
reactive
oxygen
species
(ROS).
Catalase
stands
out
as
paramount
enzymatic
antioxidant.
It
efficiently
catalyzes
decomposition
hydrogen
peroxide
(H
Cell Death Discovery,
Год журнала:
2025,
Номер
11(1)
Опубликована: Янв. 24, 2025
Abstract
Free
radicals,
characterized
by
the
presence
of
unpaired
electrons,
are
highly
reactive
species
that
play
a
significant
role
in
human
health.
These
molecules
can
be
generated
through
various
endogenous
processes,
such
as
mitochondrial
respiration
and
immune
cell
activation,
well
exogenous
sources,
including
radiation,
pollution,
smoking.
While
free
radicals
essential
for
certain
physiological
signaling
defense,
their
overproduction
disrupt
delicate
balance
between
oxidants
antioxidants,
leading
to
oxidative
stress.
Oxidative
stress
results
damage
critical
biomolecules
like
DNA,
proteins,
lipids,
contributing
pathogenesis
diseases.
Chronic
conditions
cancer,
cardiovascular
diseases,
neurodegenerative
disorders,
inflammatory
diseases
have
been
strongly
associated
with
harmful
effects
radicals.
This
review
provides
comprehensive
overview
characteristics
types
mechanisms
formation,
biological
impacts.
Additionally,
we
explore
natural
compounds
extracts
studied
antioxidant
properties,
offering
potential
therapeutic
avenues
managing
radical-induced
damage.
Future
research
directions
also
discussed
advance
our
understanding
treatment
radical-associated
Antioxidants,
Год журнала:
2022,
Номер
11(10), С. 2049 - 2049
Опубликована: Окт. 18, 2022
In
the
last
few
decades,
endocannabinoids,
plant-derived
cannabinoids
and
synthetic
have
received
growing
interest
as
treatment
options
in
neurodegenerative
conditions.
various
experimental
settings,
they
displayed
antioxidative,
anti-inflammatory,
antiapoptotic,
immunomodulatory,
neuroprotective
effects.
However,
due
to
numerous
targets
downstream
effectors
of
their
action,
cellular
molecular
mechanisms
underlying
these
effects
are
rather
complex
still
under
discussion.
Cannabinoids
able
neutralize
free
radicals
modulate
production
reactive
oxygen
species
activity
antioxidative
systems
acting
on
CB1
CB2
cannabinoid
receptors.
The
activation
receptors
stimulates
signaling
pathways
involved
defense
survival
(such
phosphoinositide
3-kinase
(PI3K)/Akt,
mitogen-activated
protein
kinase
(MAPK),
Nrf2
pathways)
regulates
glutamatergic
signaling,
N-methyl-D-aspartate
(NMDA)
receptors,
calcium
influx,
induction
Ca2+-regulated
cascades,
whereas
mediated
by
suppression
microglial
release
prooxidative
proinflammatory
mediators.
This
review
summarizes
main
new
advances
understanding
cannabinoids.
Because
plethora
possible
pharmacological
interventions
related
oxidative
stress
cannabinoid-mediated
neuroprotection,
future
research
should
be
directed
towards
a
better
interplay
between
activated
signal
transduction
with
aim
improve
efficacy
targeting
endocannabinoid
system.
International Journal of Immunopathology and Pharmacology,
Год журнала:
2025,
Номер
39
Опубликована: Янв. 1, 2025
Knowledge
about
total
RNA
molecules
in
Parkinson’s
disease
is
limited.
This
gene
expression
profiling
study
was
conducted
with
a
preclinical
experimental
design
using
mouse
model
to
examine
the
molecular-biological
characteristics
and
pathological
implication
of
interaction
silico.
In
silico
analysis
molecules,
Gene
Expression
Omnibus
database,
published
results,
preliminary
findings
available
patient
samples
apply.
The
potential
signaling
network
effect
predicted
confirmed.
research
consists
four
parts.
At
first,
we
analyzed
control
MPTP
groups.
second
part,
FVB-N
MPTP.
third
controls.
fourth
MTPT
separately.
constructed
contains
RNA,
where
Kyoto
Encyclopedia
Genes
Genomes
database
showed
that
genes
from
pathway
are
involved
development
complications
male
female
rats.
Identified
altered
signaling.
There
direct
interconnection
interdependence
interactions
network.
Results
identified
significant
total-RNA
connect
other
molecules.
shows
upregulated
downregulated
Preliminary
data
interact
genes,
they
applicable
course
monitoring,
shedding
light
on
how
factors
impact
offering
strategies
for
management.
Brain Research Bulletin,
Год журнала:
2025,
Номер
unknown, С. 111253 - 111253
Опубликована: Фев. 1, 2025
Neurodegenerative
diseases
(NDDs)
are
a
class
of
cognitive
and
motor
disorders
including
Alzheimer's
disease
(AD),
Parkinson's
(PD),
Huntington's
(HD),
Amyotrophic
Lateral
Sclerosis
(ALS),
others.
They
caused
by
lesions
in
cells
tissues
the
central
nervous
system,
resulting
corresponding
dysfunctions
consequent
decline
functions.
Neural
extremely
vulnerable
to
oxidative
stress,
which
plays
critical
biological
roles
NDDs.
Aromatic
compounds
found
extensively
natural
plants
have
substantial
effects
anti-oxidative
stress
damage,
not
only
wide
range
research
applications
cosmetics,
foods,
etc.,
but
also
frequently
utilized
treatment
various
system
diseases.
This
review
summarizes
relevant
mechanisms
NDDs
(AD,
PD,
HD,
ALS)
reviews
aromatic
such
as
polyphenols,
terpenoids,
flavonoids
that
can
be
used
management
neurodegenerative
diseases,
well
their
specific
antioxidant
action.
will
serve
reference
for
future
experimental
studies
on
illnesses
while
offering
fresh
insights
into
clinical
therapy.
Pharmaceutics,
Год журнала:
2025,
Номер
17(3), С. 284 - 284
Опубликована: Фев. 20, 2025
Cognitive
aging,
characterized
by
the
gradual
decline
in
cognitive
functions
such
as
memory,
attention,
and
problem-solving,
significantly
impacts
daily
life.
This
is
often
accelerated
neurodegenerative
diseases,
particularly
Alzheimer’s
Disease
(AD)
Parkinson’s
(PD).
AD
marked
accumulation
of
amyloid-beta
plaques
tau
tangles,
whereas
PD
involves
degeneration
dopaminergic
neurons.
Both
conditions
lead
to
severe
impairment,
greatly
diminishing
quality
life
for
affected
individuals.
Recent
advancements
regenerative
medicine
have
highlighted
mesenchymal
stromal
cells
(MSCs)
their
derived
exosomes
promising
therapeutic
options.
MSCs
possess
regenerative,
neuroprotective,
immunomodulatory
properties,
which
can
promote
neurogenesis,
reduce
inflammation,
support
neuronal
health.
Exosomes,
nanosized
vesicles
from
MSCs,
provide
an
efficient
means
delivering
bioactive
molecules
across
blood–brain
barrier,
targeting
underlying
pathologies
PD.
While
these
therapies
hold
great
promise,
challenges
variability
MSC
sources,
optimal
dosing,
effective
delivery
methods
need
be
addressed
clinical
application.
The
development
robust
protocols,
along
with
rigorous
trials,
crucial
validating
safety
efficacy
exosome
therapies.
Future
research
should
focus
on
overcoming
barriers,
optimizing
treatment
strategies,
exploring
integration
lifestyle
interventions.
By
addressing
challenges,
MSC-
exosome-based
could
offer
transformative
solutions
improving
outcomes
enhancing
individuals
aging
diseases.
Current Issues in Molecular Biology,
Год журнала:
2025,
Номер
47(3), С. 174 - 174
Опубликована: Март 6, 2025
Parkinson's
disease
(PD)
is
the
second
most
common
neurodegenerative
disease,
and
its
prevalence
expected
to
double
in
next
30
years.
Currently,
no
effective
treatment
exists
for
disease.
Thus,
research
has
focused
on
discovering
new
natural
compounds
with
strong
neuroprotective
potential.
This
study
aimed
investigate
effects
of
methanol
extract
Desmodesmus
arthrodesmiformis
EM13
(DaMe)
mitochondrial
damage
pathway
an
vitro
model
PD.
The
isolate
was
first
grown
under
appropriate
culture
conditions,
then
prepared
use
experiments.
total
lipid
protein
contents,
fatty
acid
composition,
elemental
content
DaMe
were
subsequently
determined.
Human
SH-SY5Y
neuroblastoma
cells
pretreated
nontoxic
concentrations
before
6-hydroxydopamine
(6-OHDA)
toxicity.
Pretreatment
at
100,
250,
500
µg/mL
showed
a
effect
6-OHDA-induced
by
decreasing
reactive
oxygen
species
(ROS)
production,
oxidant
status
(TOS),
increasing
antioxidant
capacity
(TAC),
membrane
potential
(ΔΨm),
oxidative
DNA
damage,
regulating
gene
expressions
related
PD
apoptosis.
Given
results
our
study,
we
suggest
that
can
be
used
as
source
producing
drugs
dietary
supplements
intended
treat